Iguana Healthcare Management’s Pacific Biosciences PACB Stock Holding History

Iguana Healthcare Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-215,000	Closed	-$1.11M	–	70
2017 Q1	$1.11M	Buy	215,000 +65,000	+43%	+$318K	0.55%	53
2016 Q4	$570K	Sell	150,000 -150,000	-50%	-$1.09M	0.34%	56
2016 Q3	$2.69M	Buy	300,000 +200,000	+200%	+$1.67M	0.48%	59
2016 Q2	$704K	Buy	100,000 +25,000	+33%	+$228K	0.29%	71
2016 Q1	$638K	Buy	+75,000	New	+$738K	0.23%	67
2015 Q3	–	Sell	-275,000	Closed	-$1.58M	–	80
2015 Q2	$1.58M	Buy	275,000 +125,000	+83%	+$723K	0.5%	48
2015 Q1	$876K	Buy	+150,000	New	+$1.03M	0.37%	55

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Iguana Healthcare Management's PACB Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Pacific Biosciences (PACB) in Q2 2017, closing a stake of 215,000 shares — an estimated $1.11M sold.

Iguana Healthcare Management first reported a position in PACB in Q1 2015 and held it in 7 quarters. The position peaked at $2.69M in Q3 2016. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2017.

Iguana Healthcare Management reported no remaining Pacific Biosciences position as of Q2 2017 after selling out during the quarter.
Iguana Healthcare Management sold 215,000 Pacific Biosciences shares in Q2 2017, an estimated $1.11M.
Iguana Healthcare Management first reported a position in Pacific Biosciences in Q1 2015 and held it in 7 quarters.
Iguana Healthcare Management's Pacific Biosciences position peaked at $2.69M in Q3 2016.
107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.